5ZV2
FGFR-1 in complex with ligand lenvatinib
Summary for 5ZV2
Entry DOI | 10.2210/pdb5zv2/pdb |
Descriptor | Fibroblast growth factor receptor 1, 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide (3 entities in total) |
Functional Keywords | fgf receptor kinase, transferase-transferase inhibitor complex, biosynthetic protein, transferase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 70503.82 |
Authors | Matsuki, M.,Hoshi, T.,Yamamoto, Y.,Ikemori-Kawada, M.,Minoshima, Y.,Funahashi, Y.,Matsui, J. (deposition date: 2018-05-09, release date: 2018-07-11, Last modification date: 2023-11-22) |
Primary citation | Matsuki, M.,Hoshi, T.,Yamamoto, Y.,Ikemori-Kawada, M.,Minoshima, Y.,Funahashi, Y.,Matsui, J. Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models. Cancer Med, 7:2641-2653, 2018 Cited by PubMed: 29733511DOI: 10.1002/cam4.1517 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.86 Å) |
Structure validation
Download full validation report